Esperante Development BV

Esperante Development’s objective is to enable discovery and formulation of novel medical treatments to support better outcomes for healthcare professionals, their patients, pharmaceutical partners and the Sever Life Sciences group. Esperante Development is active across multiple therapies, but is currently focused on the development of novel products, and innovative treatments in Ophthalmology and sterile products.

We manage the full development of a wide medical portfolio that covers multiple therapeutic areas and can support and manage a project’s journey through clinical phases with our team of industry experts. Our experienced leadership team form an actively integrated component guiding the seamless team collaboration in delivery of successful outcomes.

Véronique Rabours-Mory
Chief Executive Officer
View Profile
Visit Esperante Development